Login

Create Account

AAOS 2025 Registration Is Now Open! Sign Up Early and Save.

AAOS.org is currently experiencing longer than usual load times when logging in. We are working to correct this issue and hope to resolve it shortly. We apologize for the inconvenience and thank you for your patience.

AAOS Now, May 2021

Off-label Use of Medications, Biologics, and Devices in Orthopaedic Trauma Creates a Bevy of Risks and Challenges

Arun Aneja, MD, PhD; Jonathan Grabau, MD

Following FDA approval, any marketing or promotion of a given medications, biologics, and devices (MBD) is strictly restricted to the approved indication. Discretion on how to use devices on the market for patients is the responsibility of clinicians.

AAOS Now, May 2021

Off-label Use of Medications, Biologics, and Devices in Orthopaedic Trauma Creates a Bevy of Risks and Challenges